CBS 2019
CBSMD教育中心
中 文

Congestive Heart Failure

Abstract

Recommended Article

Left Ventricular Assist Device as a Bridge to Recovery for Patients With Advanced Heart Failure Lower Risk of Heart Failure and Death in Patients Initiated on SGLT-2 Inhibitors Versus Other Glucose-Lowering Drugs: The CVD-REAL Study Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes Percutaneous Atriotomy for Levoatrial–to–Coronary Sinus Shunting in Symptomatic Heart Failure: First-in-Human Experience Sex Differences in Cardiovascular Pathophysiology: Why Women Are Overrepresented in Heart Failure With Preserved Ejection Fraction 2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America HFpEF: From Mechanisms to Therapies Left Ventricular Assist Devices for Lifelong Support

JOURNAL: Article Link

南京市第一医院心血管内科为多名复杂性肺高压患者实施肺血管介入治疗

qiaomingyue Keywords: 近年来,肺动脉高压在病理机制、诊断、风险评估及治疗等方面有诸多新进展,治疗策略不断更新,交感神经学说在肺动脉高压发生及发展中起着重要作用。经皮肺动脉去神经术(percutaneous pulmonary artery denervation,PADN)由陈绍良教授创新发明并成功开展后,越来越多的研究证据均显示其良好的疗效及广阔的前景,随着这一技术在全球的普及,肺动脉高压的治疗已经迈入在靶向药物治疗基础上的介入治疗新时代。

网站资料更新中...